It's likely that millions of COVID-19 booster shots will be administered in the U.S. in the coming months, but that doesn’t mean companies like Moderna and Pfizer will report an unexpected revenue windfall this year.
MarketWatch.com - Top Stories, MarketWatch
Wed, 09/22/2021 - 6:08pm
It's likely that millions of COVID-19 booster shots will be administered in the U.S. in the coming months, but that doesn’t mean companies like Moderna and Pfizer will report an unexpected revenue windfall this year.